Get the Stockscreener App
165.75
2.54%
4.11
Ishares Biotechnology Etf Stock (IBB) Forecast
The Ishares Biotechnology Etf (IBB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $193.34, representing a +16.65% increase from the current price of $165.75. The highest analyst price target is $200.72, and the lowest is $185.95.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IBB Price Target
Average 186.91
(+12.77% Upside)
Is Ishares Biotechnology Etf (IBB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.11 | Neutral |
| STOCH(9,6) | 20.34 | Neutral |
| STOCHRSI(14) | 71.92 | Neutral |
| MACD(12,26) | -2.5492 | Sell |
| ADX(14) | 23.45 | Neutral |
| William %R | -57.79 | Neutral |
| CCI(14) | -22.28 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
164.60
Buy
|
165.05
Buy
|
| MA20 |
168.15
Sell
|
167.24
Sell
|
| MA50 |
171.48
Sell
|
169.25
Sell
|
| MA100 |
169.54
Sell
|
166.21
Sell
|
| MA200 |
154.05
Buy
|
157.91
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, IBB could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on IBB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.11 indicates that IBB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.34 indicates that IBB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.92 indicates that IBB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.45 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -22.28 indicates that IBB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IBB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ishares Biotechnology Etf financial reports and earnings history, Ishares Biotechnology Etf (IBB) stock could reach $154.67 by 2030, $221.54 by 2040 and $270.80 by 2050. See the projected annual prices until 2050 of the Ishares Biotechnology Etf stock below:
- Ishares Biotechnology Etf (IBB) is expected to reach an average price of $179.21 in 2035, with a high prediction of $180.65 and a low estimate of $171.52. This indicates an $8.12% rise from the last recorded price of $165.75.
- Ishares Biotechnology Etf (IBB) stock is projected to chart a bullish course in 2040, with an average price target of $218.27, representing an $31.68% surge from its current level. The forecast ranges from a conservative $215.17 to a sky-high $221.54.
- Our analysts predict Ishares Biotechnology Etf (IBB) to jump 40.72% by 2045, soaring from $227.69 to an average price of $233.24, potentially reaching $243.06. While $227.69 is the low estimate, the potential upside is significant.
- Ishares Biotechnology Etf (IBB) stock is expected to climb by 2050, reaching an average of $270.73, a $63.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $270.80 and $258.24, respectively, highlighting the market's uncertainty.
Ishares Biotechnology Etf Stock (IBB) Year by Year Forecast
Ishares Biotechnology Etf Stock (IBB) Price Forecast for 2026
The predicted value for Ishares Biotechnology Etf (IBB) in 2026 is set at an average of $179.61. Estimates vary from a peak of $204.61 to a trough of $154.62, indicating an +8.36% surge from the present price of $165.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $193.01 | $185.95 | $200.72 | +16.45% |
| May, 2026 | $182.67 | $169.21 | $192.00 | +10.21% |
| June, 2026 | $175.59 | $171.64 | $185.53 | +5.94% |
| July, 2026 | $176.64 | $170.01 | $186.29 | +6.57% |
| August, 2026 | $189.15 | $174.63 | $190.67 | +14.12% |
| September, 2026 | $190.29 | $183.21 | $192.91 | +14.80% |
| October, 2026 | $199.33 | $184.27 | $202.09 | +20.26% |
| November, 2026 | $199.58 | $191.53 | $204.61 | +20.41% |
| December, 2026 | $189.00 | $188.55 | $203.34 | +14.02% |
Ishares Biotechnology Etf Stock (IBB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ishares Biotechnology Etf (IBB) is $162.44, with a high forecast of $192.34 and a low forecast of $132.53. This indicates an -2.00% decrease from the last price of $165.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $185.87 | $180.81 | $187.58 | +12.14% |
| February, 2027 | $182.11 | $179.96 | $192.34 | +9.87% |
| March, 2027 | $182.11 | $170.88 | $186.02 | +9.87% |
| April, 2027 | $166.68 | $163.32 | $182.84 | +0.56% |
| May, 2027 | $158.44 | $150.27 | $164.72 | -4.41% |
| June, 2027 | $150.48 | $146.50 | $163.35 | -9.21% |
| July, 2027 | $158.29 | $146.53 | $161.66 | -4.50% |
| August, 2027 | $151.11 | $150.94 | $163.60 | -8.83% |
| September, 2027 | $147.67 | $133.52 | $152.40 | -10.91% |
| October, 2027 | $137.80 | $132.53 | $147.89 | -16.86% |
| November, 2027 | $154.98 | $138.56 | $155.47 | -6.50% |
| December, 2027 | $160.94 | $148.25 | $163.50 | -2.90% |
Ishares Biotechnology Etf Stock (IBB) Price Forecast for 2028
In 2028, Ishares Biotechnology Etf (IBB) is projected to reach an average price of $154.74, with a high projection of $167.54 and a low estimate of $141.95. This indicates an -6.64% fall from the last price of $165.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $149.69 | $148.42 | $163.37 | -9.69% |
| February, 2028 | $145.54 | $141.95 | $157.47 | -12.19% |
| March, 2028 | $157.27 | $144.67 | $158.55 | -5.12% |
| April, 2028 | $162.58 | $153.74 | $165.63 | -1.91% |
| May, 2028 | $160.89 | $158.38 | $167.54 | -2.93% |
| June, 2028 | $164.41 | $156.94 | $167.07 | -0.81% |
| July, 2028 | $161.37 | $160.13 | $167.25 | -2.64% |
| August, 2028 | $151.08 | $149.83 | $163.97 | -8.85% |
| September, 2028 | $160.24 | $151.46 | $160.47 | -3.32% |
| October, 2028 | $161.19 | $156.66 | $163.07 | -2.75% |
| November, 2028 | $158.35 | $154.61 | $161.79 | -4.46% |
| December, 2028 | $156.41 | $154.04 | $162.60 | -5.64% |
Ishares Biotechnology Etf Stock (IBB) Price Forecast for 2029
The 2029 price forecast for Ishares Biotechnology Etf Stock (IBB) is $156.54 on average, with a high prediction of $171.40 and a low estimate of $141.67. This represents an -5.56% decrease from the previous price of $165.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $158.86 | $153.58 | $161.44 | -4.16% |
| February, 2029 | $157.21 | $154.18 | $159.43 | -5.15% |
| March, 2029 | $156.32 | $156.06 | $160.37 | -5.69% |
| April, 2029 | $151.42 | $148.29 | $156.50 | -8.65% |
| May, 2029 | $145.41 | $141.67 | $152.66 | -12.27% |
| June, 2029 | $152.56 | $143.74 | $152.59 | -7.96% |
| July, 2029 | $165.89 | $151.82 | $167.89 | +0.09% |
| August, 2029 | $164.52 | $163.53 | $169.57 | -0.74% |
| September, 2029 | $168.41 | $161.47 | $169.04 | +1.60% |
| October, 2029 | $166.57 | $164.59 | $171.40 | +0.49% |
| November, 2029 | $155.12 | $154.00 | $168.74 | -6.41% |
| December, 2029 | $154.16 | $152.34 | $161.78 | -6.99% |
Ishares Biotechnology Etf Stock (IBB) Price Forecast for 2030
Ishares Biotechnology Etf Stock (IBB) is expected to reach an average price of $159.23 in 2030, with a high forecast of $175.04 and a low forecast of $143.43. This signifies an -3.93% decrease from the last price of $165.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $152.84 | $149.30 | $154.67 | -7.79% |
| February, 2030 | $155.20 | $152.53 | $160.59 | -6.37% |
| March, 2030 | $154.87 | $153.78 | $157.93 | -6.56% |
| April, 2030 | $152.64 | $151.72 | $156.49 | -7.91% |
| May, 2030 | $149.89 | $148.91 | $156.02 | -9.57% |
| June, 2030 | $155.94 | $146.28 | $157.99 | -5.92% |
| July, 2030 | $165.79 | $156.12 | $166.09 | +0.03% |
| August, 2030 | $172.72 | $166.76 | $172.74 | +4.21% |
| September, 2030 | $171.43 | $167.83 | $174.44 | +3.43% |
| October, 2030 | $173.49 | $163.66 | $174.66 | +4.67% |
| November, 2030 | $152.46 | $146.52 | $175.04 | -8.02% |
| December, 2030 | $156.93 | $143.43 | $160.45 | -5.32% |
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):